What should you know about superficial bladder cancer?

The term may include non-muscle-invasive bladder cancer, including disease confined to the bladder lining or involving the layer just beneath it. Your pathology report helps the care team judge how deeply the tumour has grown and how active its cells look.

Bladder cancer begins in cells lining the inside of the bladder. A superficial tumour has not invaded the muscle layer, which affects the treatment approach, but its behaviour still depends on features such as tumour size, number, appearance, grade, and whether it has come back before.

Blood in the urine is a common warning sign, although other urinary problems can cause the same symptom. Some people notice burning, frequent urination, urgency, or difficulty passing urine. These symptoms do not establish a cancer diagnosis; testing is needed.

Assessment often includes a urine sample, imaging when appropriate, and cystoscopy, which lets a specialist inspect the bladder lining. A tissue sample removed during a procedure can clarify the diagnosis and depth of invasion. Read more about [Bladder Cancer](/conditions/bladder-cancer/) and [Cystoscopy](/treatments/diagnostics-and-staging/cystoscopy/).

Treatment is selected from the tumour findings and your general health. A procedure through the urinary passage may remove visible tumours and provide tissue for examination. Some people then receive medicine placed directly into the bladder, such as intravesical BCG therapy or another bladder treatment, to lower the chance of further tumours.

Follow-up cystoscopies and urine tests may be arranged because new growths can appear even after an initial tumour has been removed. Keep each appointment and tell the team about new urinary symptoms, blood in the urine, fever, or difficulty passing urine. Treatments such as chemotherapy, immunotherapy, or bladder removal surgery are considered in particular situations, including disease that returns, has high-risk features, or reaches deeper tissue.

You can review [Intravesical BCG Therapy](/treatments/systemic-therapy/intravesical-bcg-therapy/), [Chemotherapy](/treatments/systemic-therapy/chemotherapy/), and [Immunotherapy](/treatments/systemic-therapy/immunotherapy/) to understand treatment terms your clinician may use.

Arrange medical assessment for visible blood in the urine, repeated urinary irritation, or a change in your usual urine flow, even if the symptom settles. Prompt review is also needed for difficulty passing urine, because blockage can require urgent treatment. Seek urgent help if you cannot pass urine, have severe lower abdominal pain, feel faint, or have heavy bleeding or clots.

After a bladder procedure or treatment, contact your care team promptly for fever, chills, worsening pain, vomiting, or inability to urinate. These symptoms may signal infection, bleeding, or another complication that needs direct assessment. More information is available under [Difficulty Passing Urine](/symptoms/difficulty-passing-urine/).

Ask which layer the tumour reached, what grade was reported, whether it was completely removed, and what features affect the chance of recurrence. Ask when your next cystoscopy is due, whether bladder treatment is recommended, and which symptoms should trigger a same-day call. If deeper invasion is found, ask how the plan would change and whether bladder removal surgery is being considered.